A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Relapsing Forms of Multiple Sclerosis

Interventions

PROCEDURE

Plasma exchange

DRUG

natalizumab treatment

Trial Locations (2)

Cleveland Clinic Mellen Center for MS, Cleveland

Center for Neurological Disorders, Aurora Health Care, Milwaukee